Scientific and Clinical Advisors
Doctor Ilya Chumakov
Pharnext co-founder, SAB Chairman
Pharnext CSO until 2014. Pioneer in genetics, genomics and molecular pharmacology. Former Director at CEPH, Genset and Serono. Author of more than 90 articles, inventor of more than 60 patents.
Professor Eric R. Kandel
Columbia University, New York, USA
Nobel Prize in Medicine in 2000. World expert in Neurosciences and Professor of Biochemistry and Biophysics at Columbia University.
Professor Jean-Marie Lehn
University of Strasbourg, France
Nobel Prize in Chemistry in 1987. Early innovator in the field of supramolecular chemistry. He has published in excess of 900 peer-reviewed articles in chemistry litterature.
Doctor David Cornblath
The Johns Hopkins University, Baltimore, USA
Expert in peripheral nerve disorders. Professor of Neurology and Neurosurgery. Editor-in-Chief of the Journal of the Peripheral Nervous System and the Journal of the Peripheral Nerve Society.
Professeur Richard Lewis
Cedars-Sinai Specialty Clinic, Los Angeles, USA
Director of the Electromyography Lab, co-Director of the Neuromuscular Clinic. World expert in inflammatory and inherited neuro-degenerative disorders. Discovered the Lewis-Sumner syndrome.
Professor Klaus Nave
Max Planck institute, Göttingen, Germany
World expert in Neurobiology, leader in Charcot-Marie-Tooth. Director of the Max Planck Institute for Experimental Medicine, Professor of Biology at the University of Heidelberg.
Professor Michael Sereda
Max Planck Institute, Göttingen, Germany
World expert in CMT1A preclinical and clinical work, group leader “Molecular and Translational Neurology”. Specialist in hereditary neuropathies, creator of the PMP22 transgenic rat model.
Professor Jean-Michel Vallat
University of Limoges, France
World renown clinician and pathologist of Peripheral Nerve disorders, especially for Charcot-Marie-Tooth disease.
Professor Jean-Marc Orgogozo
University of Bordeaux, France
Expert in Neurology and Clinical Pharmacology, particularly in Alzheimer's disease and dementia. Past-head of the Clinical Neuroscience Department, CHU Hospital Pellegrin in Bordeaux.
Professor Anthony Schapira
University College, London, UK
Professor of Neurology, Head of Clinical Neuroscience and Chairman of Clinical Neurosciences Specialties. World renown expert in Parkinson’s disease and other neurodegenerative disorders.
Professor Fabio Macciardi
University of California, Irvine, USA
Professor in Molecular Psychiatry. Research interests in the non-coding genome of complex psychiatric traits and methods of genetic epidemiology.
Professor Richard Frackowiak
C.H.U. Vaudois, Lausanne, Switzerland
Worldwide-renowned brain imaging specialist. Director of the Clinical Neuroscience Department at the University of Lausanne.
Doctor Magid Abou Gharbia
Temple University, Philadelphia, USA
Associate Dean for Research, Professor of Medicinal Chemistry and Director of he Moulder Center for Drug Discovery Research at the School of Pharmacy, Temple University, Philadelphia.
Professor Michel Marre
Hospital Bichat-Claude Bernard, Paris, France
World expert in diabetes and related complications, notably nephropathy. Head of Endocrinology, Diabetology and Metabolic Disorders Departement at the Bichat-Claude Bernard Hospital, Paris.
Doctor Alan Smith
Genzyme Corporation, Cambridge, USA
Formerly Chief Scientific Officer at Genzyme for more than 15 years. Fellow of the Royal Society of London and of Christ's College Cambridge.
Professor David Klatzmann
Hospital Pitié-Salpêtrière, Paris, France
Worldwide-renowned immunologist and expert in biotherapies.
Doctor Salem Chouaib
Institut Gustave Roussy, Villejuif, France
Curent Head of Research at INSERM Unit 753, Human Cancer Immunology and Immunotherapy.